AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting

AcelRx Pharmaceuticals, Inc.

today announced that multiple moderated poster presentations will be made at the American College of Surgeons (ACS 2014) Clinical Congress October 26th to October 30th, 2014 at the Moscone Center in San Francisco, CA. The annual ACS meeting is one of the largest international meetings of surgeons in the world. Pamela Palmer, M.D. Ph.D. will present safety and efficacy data from the phase 3 trials evaluating the Zalviso™ sufentanil sublingual tablet system for the treatment of moderate-to-severe acute pain. Details on the presentation times are as follows: Wednesday, October 29, 2014 – Poster Session PP20, Poster 51175 – Presentation time 11:30-1:00pm (local time) Authors: Forrest G. Ringold, MD, Harold S. Minkowitz, MD, Tong-Joo Gan, MD, Keith A. Aqua, MD and Pamela P. Palmer, MD, PhD Title: SUFENTANIL SUBLINGUAL TABLET SYSTEM EFFICACY AND FUNCTIONALITY FOLLOWING MAJOR ABDOMINAL SURGERY IN YOUNG AND ELDERLY ADULT PATIENTS Wednesday, October 29, 2014 – Poster Session PP20, Poster 51199 – Presentation time 11:30-1:00pm (local time) Authors: Harold S. Minkowitz, MD, Tong-Joo Gan, MD and Pamela P. Palmer, MD, PhD Title: SUFENTANIL SUBLINGUAL TABLET SYSTEM ONSET OF ANALGESIA COMPARED TO IV PATIENT-CONTROLLED ANALGESIA WITH MORPHINE - A PHASE 3 META-ANALYSIS